The drug, which goes by the brand name Nucynta, is already approved for acute pain.
Tapentadol is a centrally acting synthetic analgesic. This oral mu-opioid agonist is taken twice daily in adults when a continuous, around-the-clock analgesic is needed over an extended time period.
Related Articles on FDA Device Approvals:
Technological Changes Affecting Eye ASCs: Q&A With Larry Patterson of Eye Centers of Tennessee
French Diagnostics Company Receives FDA Approval for MRSA Test
FDA Approves Solesta to Treat Life-Altering Fecal Incontinence
